SPRY2 and pancreatic neoplasm: It promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2, and the mechanistic revealed that miR-21 targeted MAPK/ERK and PI3K/AKT signaling pathways to modulate cell proliferation [71].